eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapiesLise Boussemart, Stéphan Vagner, Oskar Hemmingsson et al.|Nature|2014Cited by 361
Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF–CRAF HeterodimerizationLise Boussemart, Caroline Robert, Isabelle Girault et al.|Cancer Research|2016Cited by 51